Emergent BioSolutions Inc... (EBS)
NYSE: EBS
· Real-Time Price · USD
9.27
0.08 (0.87%)
At close: Oct 03, 2025, 2:29 PM
0.87% (1D)
| Bid | 9.23 |
| Market Cap | 494.3M |
| Revenue (ttm) | 846.2M |
| Net Income (ttm) | 139.5M |
| EPS (ttm) | 2.62 |
| PE Ratio (ttm) | 3.54 |
| Forward PE | 9.02 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 9.35 |
| Volume | 317,395 |
| Avg. Volume (20D) | 1,155,493 |
| Open | 9.23 |
| Previous Close | 9.19 |
| Day's Range | 9.13 - 9.36 |
| 52-Week Range | 4.02 - 12.73 |
| Beta | 2.04 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for EBS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEmergent BioSolutions Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+9.26%
Emergent BioSolutions shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+36.65%
Emergent BioSolutions shares are trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · seekingalpha.com
Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 RallyEmergent BioSolutions delivered a strong Q2 2025, beating its own guidance and showing major improvements in margins. EBS has a sound turnaround strategy that is showing signs of success. The company ...
